1.A Case of Transseptal Approach to Carotid Artery Stenting in Right Internal Carotid Stenosis.
Woong Chol KANG ; Young Sup YUN ; Donghoon CHOI ; Won Heum SHIM
Korean Circulation Journal 1998;28(8):1409-1413
Although the carotid endarterectomy presently represents the standard therapeutic approach for most patients with significant carotid artery stenosis, a percutaneous transluminal angioplasty (PTA) with stenting has become an alternative method for treating patients with co-mobid conditions, particulary coronary artery disease. A PTA with stenting has the potential for being safer, less traumatic, more cost-effective, and useful in patients at high surgical risk. As well, they are not limited to the cervical carotid artery. But it is reported that carotid angioplasty by femoral approach is difficult to do in 1 - 2% of patients with carotid stenosis due to abnormal origin of carotid artery or occlusion of femoral arteries. We succeeded in PTA with stenting of tight stenosis of right internal carotid artery through the transseptal approach in case of a sharply angled right brachiocephalic artery take-off from the aorta. The transseptal approach can be used for PTA with stenting in case of problems with femoral approach.
Angioplasty
;
Aorta
;
Arteries
;
Carotid Arteries*
;
Carotid Artery, Internal
;
Carotid Stenosis*
;
Constriction, Pathologic
;
Coronary Artery Disease
;
Endarterectomy, Carotid
;
Femoral Artery
;
Humans
;
Stents*
3.The Study of BD-MSC Therapy against Critical Limb Ischemia.
Myeongjoo SON ; Woong Chol KANG ; Kyunghee BYUN
Korean Journal of Physical Anthropology 2016;29(2):61-69
Critical limb ischemia (CLI) is the most severe peripheral artery disease and caused by thrombus formation in blood vessel. The current strategies for treating CLI does not protect limb amputation and reduction in the risk of mortality. Recently, human bone marrow derived mesenchymal stem cells (BD-MSC) were reported to have a paracrine effects on angiogenesis in several ischemic diseases. So, we validate to determine whether BD-MSC protect against ferric chloride treated CLI and induce angiogenesis. To characterized human bone marrow derived stem cell, BD-MSC differentiated to osteocytes and adipocytes and validated stemness using flow cytometry. Endothelial cell induced angiogenesis followed by mesenchymal stem cell cultured medium treatment in HUVEC in vitro. We also mimicked CLI patients condition using FeCl₃ treated CLI mouse and injected one hundred thousand of BD-MSC along the femoral artery to leg muscle. We validated stem cell survival, blood vessel formation, leg muscle condition and fibrosis compared by saline injected mice 28 days later. In this study, BD-MSC cultured medium treatment increased migration and tube formation of HUVEC and BD-MSC injection had an effective blood vessel formation in FeCl₃ treated CLI. As well as blood vessel formation, limb salvage rate also improved and fibrosis area statistically decreased in BD-MSC injected mice. In conclusion, bone marrow derived mesenchymal stem cell improved not only blood vessel formation but also reduction of fibrosis in FeCl₃ treated CLI mice and finally protected limb amputation.
Adipocytes
;
Amputation
;
Animals
;
Blood Vessels
;
Bone Marrow
;
Endothelial Cells
;
Extremities*
;
Femoral Artery
;
Fibrosis
;
Flow Cytometry
;
Humans
;
In Vitro Techniques
;
Ischemia*
;
Leg
;
Limb Salvage
;
Mesenchymal Stromal Cells
;
Mice
;
Mortality
;
Osteocytes
;
Peripheral Arterial Disease
;
Stem Cells
;
Thrombosis
4.Endovascular Therapy for Thoracic Aortic Aneurysm.
Korean Journal of Medicine 2015;89(4):381-388
Endovascular therapy, proposed as an alternative to surgery, is considered a therapeutic innovation because of its low degree of invasiveness, allowing for the treatment of high-risk surgical patients and outcomes of limited complications and mortality. The combination of endovascular exclusion with cerebral branch revascularization for the treatment of thoracic aortic aneurysms involving arch has also been attempted. With improved capability to recognize proper anatomy and select clinical candidates, endovascular therapy may offer a strategy to optimize management and improve prognosis for thoracic aortic aneurysm patients.
Aortic Aneurysm, Thoracic*
;
Humans
;
Mortality
;
Prognosis
6.A Case of Hepatoma extension to Right Atrium.
Geuru HONG ; Wook Jin CHUNG ; Woong Chol KANG ; Seokmin KANG ; Se Joong RIM ; Namsik CHUNG
Journal of the Korean Society of Echocardiography 2002;10(2):5-7
No abstract available.
Carcinoma, Hepatocellular*
;
Heart Atria*
7.Symptomatic Renal Artery Aneurysm Dealt with Aneurysmectomy and Patch Closure.
Jinmo KANG ; Woong Chol KANG ; Sang Tae CHOI ; Won Suk LEE ; Jeong Ho KIM
Journal of the Korean Society for Vascular Surgery 2012;28(1):48-51
Renal artery aneurysm (RAA) is a rare disease, and the precise incidence has not been very well known. It appears that with the increasing use of diagnostic ultrasound, computed tomography and arteriography, RAA are being identified more frequently than in the past. Rupture of RAA is associated with 10% mortality and the chance of nephrectomy is very high. Although, most of renal artery aneurysms are treated by endovascular technique, surgery is often necessary for aneurysms associated with bifurcation area or large braches. Here, we report a case of saccular renal artery aneurysm which was managed by open surgery.
Aneurysm
;
Angiography
;
Endovascular Procedures
;
Incidence
;
Nephrectomy
;
Rare Diseases
;
Renal Artery
;
Rupture
8.Pseudo-no-Reflow Phenomenon in Carotid Artery Stenting using FilterWire EX: Successful Recovery by Aspiration Thrombectomy.
Seung Hwan HAN ; Woong Chol KANG ; Tae Hoon AHN ; Eak Kyun SHIN
Journal of Korean Medical Science 2009;24(5):967-969
Distal protection devices such as FilterWire EX have been widely used in carotid artery stenting, however, the large amount of atherothrombotic debris entrapped in the filter could reduce or stop antegrade flow. We present a case of pseudo-no-reflow phenomenon after postdilatation of the stent in a patient with asymptomatic carotid artery stenosis. After several passes using an Export Aspiration catheter, normal flow in the internal carotid artery was restored. Aspiration thrombectomy can successfully recover pseudo-no-reflow phenomenon.
Aged
;
Blood Vessel Prosthesis Implantation
;
Carotid Arteries/radiography/surgery
;
Carotid Stenosis/diagnosis/radiography/*surgery
;
Humans
;
Male
;
*No-Reflow Phenomenon
;
Stents
;
Thrombectomy/*instrumentation
9.A Case of Hydroxyzine Induced Torsades de Pointes.
Jin Wuk KWON ; Woong Chol KANG ; Moon Hyoung LEE ; Shin Ki AHN ; Sung Soon KIM
Korean Circulation Journal 1998;28(6):1011-1016
Torsades de pointes is a polymorphic ventricular tachycardia associated with prolonged QT interval and increased U wave amplitude. It has been found to be induced by various drugs, electrolyte imbalances, and so on, but the mechanism of torsades de pointes has not been completely documented. Two hypotheses, early afterdepolarization and dispersion of repolarization have been known to be the possible mechanism. Terfenadine and astemizole are the antihistamines, known to be one of the etiologic agents of torsades de pointes, and factors associated with increased risk are significant liver disease, drug overdose, and concomitant administration of imidazole and macrolide antimicrobial drugs. There has been only one case reported that torsades de pointes had been induced by first-generation antihistamine, piprinhydrinate. We experienced a case of 43 year old male patient with torsades de pointes induced by first-generation antihistamine, hydroxyzine and treated successfully with drug cessation, MgSO
Adult
;
Astemizole
;
Drug Overdose
;
Histamine Antagonists
;
Humans
;
Hydroxyzine*
;
Isoproterenol
;
Liver Diseases
;
Male
;
Tachycardia, Ventricular
;
Terfenadine
;
Torsades de Pointes*
10.Favorable Outcome of Endovascular Stent-Graft Implantation for Stanford Type B Aortic Dissection.
Woong Chol KANG ; Bo Young JOUNG ; Young Guk KO ; Bon Kwon KOO ; Donghoon CHOI ; Do Yun LEE ; Byung Chul CHANG ; Won Heum SHIM
Korean Circulation Journal 2003;33(6):457-464
BACKGROUND AND OBJECTIVES: To evaluate the feasibility and the short- and mid-term follow-up outcomes of endovascular stent-graft implantation in patients with Stanford type B aortic dissection. SUBJECTS AND METHODS: Twenty-eight patients with Stanford type B aortic dissection were evaluated. An aortogram was performed immediately after the procedure and a follow-up computed tomography (CT) scan was performed within one week, between 3 and 6 months, and annually thereafter. Clinical status was also evaluated at the same time. RESULTS: Endovascular stent-graft implantation at the target site was successful in 27 patients (96.4%). There were primary endoleaks in 6 patients and one case of procedure failure owing to migration of the stent-graft; and no procedure-related mortality. The number of patients with early complications requiring treatment was 2 (2/27, 4%). Fourteen patients experienced postimplantation syndrome (14/27, 52%). The average follow-up period was 22.1+/-17.5 months. Complete resolution or thrombosis of the false lumen was achieved in 14 patients and partial thrombosis was achieved in 10 patients. Operative treatments were required in three patients due to a progressing dissection or new dissection. There were no deaths and no instances of aneurysm or aortic rupture during the follow-up period. CONCLUSION: Endovascular stent-graft implantation for Stanford type B aortic dissection is a feasible, safe, and effective treatment modality. All patients who underwent surgery had a persisting leak. Therefore, regular evaluation of the aortic dissection and management of endoleaks were crucial for a favorable outcome in endovascular stent-graft implantation for a Stanford type B aortic dissection.
Aneurysm
;
Aortic Rupture
;
Endoleak
;
Follow-Up Studies
;
Humans
;
Mortality
;
Thrombosis